Nanoparticle blocks key molecule involved in spread of breast cancer

Jan 19, 2011

Ongoing clinical trials have shown that a peptide known as PHSCN can slow or prevent the spread of metastatic breast cancer in over a third of patients treated with the drug. This drug works by binding to an activated receptor found on the surface of breast tumor cells but not normal cells.

Now, investigators at the University of Michigan, led by Donna Livant, have shown that attaching the PHSCN peptide to a spherical polymeric nanoparticle increases the drug's potency by as much as 6,700 fold compared to the free drug in a test designed to measure cell invasiveness. The researchers reported their findings in the journal Breast Cancer Research and Treatment.

To improve the promising performance of PHSCN, Dr. Livant and her colleagues attached eight of this peptide to a polymer nanoparticle known as a dendrimer. Tests using cultured breast showed that this construct was far more potent at preventing the invasion of those cells into an artificial membrane. Further tests in mice showed that the dendrimer-linked peptide reduced the ability of metastatic breast cancer cells to colonize the lungs of animals receiving this nanoscale construct by 3- to 5-fold compared to when animals received free PHSCN.

This work is detailed in a paper titled, "The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation." An abstract of this paper is available at the journal's website.

Explore further: Nanocontainers for nanocargo: Delivering genes and proteins for cellular imaging, genetic medicine and cancer therapy

Related Stories

Nanofibers Carry Toxic Peptides Into Cancer Cells

Apr 22, 2010

(PhysOrg.com) -- Researchers have long known that certain peptides are capable of killing cells by inserting themselves into the cell membranes and disrupting normal membrane structure and function. Now, researchers at Northwestern ...

Image-guided breast cancer therapy enabled by nanodrug

Oct 28, 2010

By combining an iron oxide nanoparticle, a tumor-targeting peptide, and a therapeutic nucleic acid into one construct, a team of investigators from the Massachusetts General Hospital and Harvard Medical School have created ...

Herceptin targets breast cancer stem cells

Jul 09, 2008

A gene that is overexpressed in 20 percent of breast cancers increases the number of cancer stem cells, the cells that fuel a tumor's growth and spread, according to a new study from the University of Michigan Comprehensive ...

Genes set scene for metastasis

Apr 11, 2007

Biologists at Memorial Sloan-Kettering Cancer Center (MSKCC) have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor. ...

Recommended for you

Engineers show light can play seesaw at the nanoscale

3 hours ago

University of Minnesota electrical engineering researchers have developed a unique nanoscale device that for the first time demonstrates mechanical transportation of light. The discovery could have major ...

Engineered proteins stick like glue—even in water

Sep 21, 2014

Shellfish such as mussels and barnacles secrete very sticky proteins that help them cling to rocks or ship hulls, even underwater. Inspired by these natural adhesives, a team of MIT engineers has designed ...

Smallest possible diamonds form ultra-thin nanothreads

Sep 21, 2014

For the first time, scientists have discovered how to produce ultra-thin "diamond nanothreads" that promise extraordinary properties, including strength and stiffness greater than that of today's strongest ...

A nanosized hydrogen generator

Sep 20, 2014

(Phys.org) —Researchers at the US Department of Energy's (DOE) Argonne National Laboratory have created a small scale "hydrogen generator" that uses light and a two-dimensional graphene platform to boost ...

User comments : 0